Variant report
Variant | nsv965099 |
---|---|
Chromosome Location | chr3:42342600-42347640 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr3:42328116..42330835-chr3:42342852..42344758,2 | K562 | blood: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs2888182 | chr3:42342619-42342620 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs561957347 | chr3:42342620-42342621 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs529553113 | chr3:42342659-42342660 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs35979826 | chr3:42342687-42342688 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs35367130 | chr3:42342707-42342708 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs1946970 | chr3:42342728-42342729 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
7 | rs77833279 | chr3:42342743-42342744 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs564983600 | chr3:42342758-42342759 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs565923688 | chr3:42342773-42342774 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs1375540 | chr3:42342774-42342775 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs144916814 | chr3:42342809-42342810 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs549499033 | chr3:42342831-42342832 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs567241176 | chr3:42342842-42342843 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs1375541 | chr3:42342871-42342872 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
15 | rs558986794 | chr3:42342872-42342873 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs1349211 | chr3:42342884-42342885 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
17 | rs538822709 | chr3:42342896-42342897 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs558510093 | chr3:42342898-42342899 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs79575025 | chr3:42342904-42342905 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs537120960 | chr3:42342954-42342955 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs17072819 | chr3:42342970-42342971 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
22 | rs573685700 | chr3:42342982-42342983 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs181430554 | chr3:42342990-42342991 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs4571218 | chr3:42343013-42343014 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
25 | rs2371893 | chr3:42343038-42343039 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
26 | rs186540718 | chr3:42343039-42343040 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs545693964 | chr3:42343078-42343079 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs565288214 | chr3:42343132-42343133 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs190104486 | chr3:42343145-42343146 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs556083324 | chr3:42343155-42343156 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs544290448 | chr3:42343160-42343161 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs560999651 | chr3:42343169-42343170 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs9682123 | chr3:42343201-42343202 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
34 | rs546662551 | chr3:42343211-42343212 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs115328333 | chr3:42343227-42343228 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs114911532 | chr3:42343230-42343231 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs115622947 | chr3:42343266-42343267 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs76911203 | chr3:42343290-42343291 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs386660513 | chr3:42343321-42343322 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs9682135 | chr3:42343323-42343324 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
41 | rs567467675 | chr3:42343364-42343365 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs9682282 | chr3:42343408-42343409 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
43 | rs572835605 | chr3:42343447-42343448 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs181547499 | chr3:42343455-42343456 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs186488187 | chr3:42343566-42343567 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs545348294 | chr3:42343582-42343583 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs559217341 | chr3:42343595-42343596 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs114802556 | chr3:42343602-42343603 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs9682293 | chr3:42343616-42343617 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
50 | rs560958979 | chr3:42343638-42343639 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Glioblastoma multiforme | 21080181 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Colorectal cancer | 21297112 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Melanoma | 18172304 | CNVD |
Cervical cancer | 21062161 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Insulin resistance | 16721378 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Oral cancer | 19627613 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Epithelial cancer | 22065749 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Liposarcoma | 21253554 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Pancreatic endocrine tumor | 20981439 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Oral cancer | 21386901 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Retinoblastoma | 21504564 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Lung cancer | 20668451 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 17603634 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Breast cancer | 17133270 | CNVD |
Uveal melanoma | 20484589 | CNVD |
Autism | 22495311 | CNVD |
Melanoma | 20688739 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Cancer | 21183584 | CNVD |
Wilms tumour | 17204608 | CNVD |
Biliary cancer | 19435499 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Kartagener syndrome | 16639409 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Bipolar disorder | 20877625 | CNVD |
Bipolar disorder | 21956041 | CNVD |
Bipolar disorder | 22241247 | CNVD |
Biliary cancer | 18923514 | CNVD |
Breast cancer | 21509527 | CNVD |
Melanoma | 21693616 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Breast cancer | 20409316 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Breast cancer | 21364760 | CNVD |
abnormal development | 18461090 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:42342600-42343600 | Enhancers | HSMM | muscle |
2 | chr3:42343200-42346000 | Enhancers | Primary B cells from peripheral blood | blood |
3 | chr3:42343800-42346200 | Enhancers | Primary B cells from cord blood | blood |
4 | chr3:42344000-42345000 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
5 | chr3:42344000-42345000 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
6 | chr3:42344000-42345200 | Enhancers | GM12878-XiMat | blood |
7 | chr3:42344200-42344800 | Enhancers | Thymus | Thymus |
8 | chr3:42344200-42345000 | Enhancers | Primary hematopoietic stem cells short term culture | blood |
9 | chr3:42344200-42345000 | Enhancers | Dnd41 | blood |
10 | chr3:42344200-42345200 | Enhancers | Primary hematopoietic stem cells | blood |
11 | chr3:42344200-42346000 | Enhancers | Fetal Thymus | thymus |
12 | chr3:42344600-42345200 | Enhancers | Primary T helper naive cells fromperipheralblood | blood |
13 | chr3:42344600-42345200 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
14 | chr3:42346000-42347600 | Weak transcription | Primary B cells from peripheral blood | blood |
15 | chr3:42347600-42348400 | Enhancers | Primary B cells from peripheral blood | blood |